The Democratic Republic of Congo's fight against Ebola in Ituri Province has taken a new turn with the launch of an experimental vaccination campaign. However, schools in the region will not be part of this initial phase. The head of the Expanded Vaccination Program (PEV) in Ituri Province, Dr. Alain Aveba, announced this during a sensitization campaign for parents at the Sainte Joséphine Bakhita school complex in Bunia, the provincial capital.
Dr. Aveba explained that the vaccination campaign will prioritize frontline healthcare workers, including doctors, nurses, laboratory technicians, and hygienists. This group is considered high-risk due to their frequent exposure to Ebola patients. The vaccination campaign will use the Ervebo vaccine, which has been homologated for the Ebola Zaire strain, not the Bundibugyo strain currently affecting Ituri Province.
The limited supply of Ervebo vaccine doses is a significant challenge for the vaccination campaign. According to Dr. Aveba, even among frontline healthcare workers, not everyone can be vaccinated immediately due to the shortage of doses. The PEV is working with partners to secure more vaccine supplies, but for now, the campaign will focus on those most at risk.
In the next phase of the vaccination campaign, contacts of confirmed Ebola cases will be targeted. These individuals, who have had direct contact with Ebola patients or their remains, will be vaccinated to prevent further spread of the disease. Dr. Aveba emphasized that only those who have been identified and registered as contacts will be eligible for vaccination at this stage.
The process of identifying and registering contacts is crucial to the success of the vaccination campaign. When a person is confirmed to have Ebola, either while alive or after death, all individuals who have had contact with them must be listed. This proactive approach aims to contain the outbreak by preventing further transmission.
The vaccination campaign is part of a broader effort to combat the Ebola outbreak in Ituri Province. The province has been experiencing an outbreak of the Bundibugyo strain of Ebola, which requires a specific vaccine. While the Ervebo vaccine has been homologated for another strain, it is being used in this case due to its availability and homologation for use in the region.
The Congolese government and its partners are working together to bring the Ebola outbreak under control. The vaccination campaign, along with other measures such as contact tracing and isolation of cases, aims to protect the population and prevent further spread of the disease.
Key points
- The experimental Ebola vaccination campaign in Ituri Province will prioritize frontline healthcare workers and contacts of confirmed cases.
- The campaign will use the Ervebo vaccine, which has been homologated for the Ebola Zaire strain.
- Schools in Ituri Province will not be part of the initial vaccination campaign due to the limited supply of vaccine doses.
